Mechanistic Insights into Aldose Reductase-Dependent Modulation of Hypoxia-Inducible Factor-1α in Promoting Renal

Wenke Zhao1, Haoyu Wang1, Jingjing Yan1

  • 1Department of Pharmacology, Wannan Medical University, Wuhu, 241002, China.

Insights

Aldose reductase (AR) drives renal fibrosis (RF) by impairing mitophagy, promoting epithelial-mesenchymal transition (EMT) in kidney cells. Inhibiting AR restores mitophagy and reverses EMT, offering a potential therapeutic target for chronic kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Renal fibrosis (RF) is the common endpoint of chronic kidney diseases.
  • Impaired mitophagy contributes to RF by promoting epithelial-mesenchymal transition (EMT) in renal tubular epithelial cells (RTECs).
  • Aldose reductase (AR) was previously shown to mediate mitophagy and promote EMT in hepatocytes.

Purpose of the Study:

  • To investigate the role of AR in RF and EMT in RTECs.
  • To elucidate the mechanisms by which AR affects mitophagy and EMT in RTECs.

Main Methods:

  • In vivo study using AR knockout in a unilateral ureteral obstruction (UUO) mouse model.
  • In vitro study involving AR knockdown or overexpression in RTECs treated with transforming growth factor-beta 1 (TGF-β1).
  • Analysis of key proteins involved in mitophagy (Pink1, Parkin, LC3, p62), EMT (Snail, α-SMA, vimentin, E-cadherin), signaling pathways (PI3K/AKT, HIF-1α), and mitochondrial function (ROS, MPTP, ΔΨm, ATP).

Main Results:

  • AR knockout mitigated RF by reducing PI3K/AKT phosphorylation, decreasing HIF-1α, increasing Pink1/Parkin, enhancing mitophagy, reducing EMT markers, and preserving mitochondrial integrity.
  • AR knockdown reversed TGF-β1-induced EMT by inhibiting HIF-1α, PI3K/AKT pathway, and MPTP opening, while restoring mitophagy and mitochondrial function.
  • AR overexpression exacerbated TGF-β1-induced EMT by promoting HIF-1α, PI3K/AKT pathway, and MPTP opening, while impairing mitophagy and mitochondrial function.

Conclusions:

  • AR facilitates EMT in RTECs and contributes to RF progression.
  • AR-induced HIF-1α expression stimulates the PI3K/AKT pathway, inhibiting Pink1/Parkin and decreasing mitophagy.
  • Targeting AR may be a potential therapeutic strategy for mitigating RF and associated EMT.